查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1700090

脑电图设备市场预测至 2032 年：按产品类型、设备类型、应用、最终用户和地区进行的全球分析

Electroencephalography Devices Market Forecasts to 2032 - Global Analysis By Product Type, Device Type, Application and End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球脑电图测量设备市场预计在 2025 年达到 15 亿美元，到 2032 年将达到 32 亿美元，预测期内的复合年增长率为 11.8%。

脑电图仪是医疗设备。它透过放置在头皮上的电极来检测脑电波模式，并有助于诊断癫痫、睡眠障碍和脑损伤等神经系统疾病。 EEG 设备范围从可携式到临床级，对于监测大脑功能和评估研究、神经病学和认知研究中的神经活动异常至关重要。

根据美国疾病管制与预防中心（CDC）的数据，到2022年，美国将有超过510万人患有癫痫病史，目前有340万人受到影响。

神经系统疾病盛行率不断上升

癫痫、阿兹海默症和帕金森氏症等神经系统疾病的盛行率不断上升，是脑电图设备需求的主要驱动因素。此外，老年人口的增加和对早期诊断的认识的提高也促进了市场的成长。此外，脑电图技术的进步使得非侵入性诊断更具吸引力，并成为监测脑部活动的首选方案。预计这一趋势将持续下去，有助于扩大市场。

开发中地区的准入受限

新兴市场对先进脑电图技术的取得有限阻碍了市场的成长。高成本和不足的医疗基础设施阻碍了这些地区的投资。此外，脑电图服务的限制性报销政策进一步限制了其采用。小型医院和诊所通常缺乏购买和维护复杂脑电图系统的资源，阻碍了其广泛应用。

人工智慧和机器学习集成

人工智慧和机器学习在脑电图分析中的整合代表着巨大的市场成长机会。这些技术将提高诊断准确性、提供预测洞察力并推动个人化医疗的创新。此外，人工智慧主导的脑电图系统可以自动解释资料，减少对专业知识的需求。此外，策略合作和研究资金对于利用这些机会和促进更复杂的 EEG 设备的开发至关重要。

与替代神经影像技术的竞争

EEG 机器面临来自 MRI、CT 和 PET 扫描等先进神经成像工具的竞争，这些工具为大脑结构评估提供了高空间解析度。儘管 EEG 具有良好的时间解析度并且具有成本效益，但单独使用它会带来挑战，因为在复杂情况下更倾向于使用多模式诊断。此外，增加对替代技术的研发投入可能会分散注意力，需要持续创新才能维持 EEG 系统的相关性。

COVID-19的影响：

COVID-19 疫情凸显了包括脑电图机在内的远端监控技术的重要性。然而，供应链中断和预算限制最初减缓了市场成长。随着经济復苏，对远端医疗和家庭监控解决方案的关注度不断提高，脑电图市场也因此受益。此外，疫情加速了数位健康技术的采用，为脑电图设备的长期成长奠定了基础。

医院和诊所部门预计在预测期内将实现最大幅度增长

由于患者数量多、基础设施先进、人力熟练，预计医院和诊所部门将在预测期内占据最大的市场占有率。在优惠报销政策的支持下，这些环境利用 EEG 进行关键诊断、手术监测和研究。此外，与学术机构合作进行临床试验增强了我们在该领域的领导地位。由于强大的医疗保健框架和神经系统疾病盛行率的上升，美国在医院脑电图应用方面处于领先地位。

穿戴式装置领域预计将在预测期内实现最高复合年增长率

受家庭监测和慢性病管理需求的推动，穿戴式装置领域预计将在预测期内实现最高成长率。轻巧的无线设计提高了患者的舒适度并实现了长期资料收集。此外，与智慧型手机和物联网平台的整合将支援即时分析，对消费者和临床医生都具有吸引力。专注于治疗癫痫和睡眠障碍的可穿戴设备的新兴企业正在推动创新，并为该行业的快速扩张做好准备。

占比最大的地区：

在预测期内，北美预计将占据最大的市场占有率，这得益于其先进的医疗保健系统、高额的研发投入以及 Natus Medical 和 Cadwell Industries 等主要企业的强大影响力。神经系统疾病的高盛行率和保险覆盖率将进一步推动需求。此外，FDA 对人工智慧增强型脑电图设备的核准以及政府对脑研究的资助正在帮助该市场保持主导地位。

复合年增长率最高的地区：

预计亚太地区在预测期内将呈现最高的复合年增长率，这得益于医疗保健服务的改善、人们对神经系统疾病的认识不断提高以及医疗旅游业的扩大。印度和中国等国家正在投资现代化诊断技术，而日本的人口老化也推动了需求。此外，与当地製造商以及提供具有成本效益的 EEG 系统的全球公司的合作正在加速市场渗透，使该地区成为高成长中心。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球脑电图测量设备市场（依产品类型）

  • 8通道脑电图
  • 21通道脑电图
  • 25通道脑电图
  • 32通道脑电图
  • 40通道脑电图
  • 多通道脑电图

第六章全球脑电图测量设备市场（以设备类型）

  • 独立设备
  • 行动装置
  • 穿戴式装置

第七章全球脑电图测量设备市场（按应用）

  • 癫痫诊断
  • 睡眠障碍的诊断
  • 脑损伤诊断
  • 失智症的诊断
  • 麻醉监测
  • 脑机介面（BCI）
  • 其他用途

第八章全球脑电图测量设备市场（按最终用户）

  • 医院和诊所
  • 诊断中心
  • 研究部门
  • 学术机构
  • 居家照护

第九章全球脑电图测量设备市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Natus Medical Incorporated
  • Medtronic plc
  • Nihon Kohden Corporation
  • Cadwell Industries, Inc.
  • NeuroWave Systems Inc.
  • Electrical Geodesics, Inc.（EGI）
  • Compumedics Limited
  • Koninklijke Philips NV
  • GE Healthcare
  • Advanced Brain Monitoring, Inc.
  • Brain Products GmbH
  • BioSemi
  • Emotiv
  • NeuroSky
  • g.tec medical engineering GmbH
  • ANT Neuro
  • Cephalon A/S
  • Noraxon USA, Inc.
Product Code: SMRC28993

According to Stratistics MRC, the Global Electroencephalography Devices Market is accounted for $1.5 billion in 2025 and is expected to reach $3.2 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Electroencephalography (EEG) devices are medical instruments used to measure and record electrical activity in the brain. They detect brain wave patterns through electrodes placed on the scalp, aiding in diagnosing neurological conditions like epilepsy, sleep disorders, and brain injuries. EEG devices range from portable to clinical-grade systems and are essential in research, neurology, and cognitive studies for monitoring brain function and assessing abnormalities in neural activity.

According to the Centers for Disease Control and Prevention (CDC), in 2022, over 5.1 million people in the U.S. had a history of epilepsy, with 3.4 million currently affected.

Market Dynamics:

Driver:

Increasing prevalence of neurological disorders

The rising incidence of neurological conditions such as epilepsy, Alzheimer's, and Parkinson's disease significantly drives the demand for EEG devices. Furthermore, the growing geriatric population and increased awareness about early diagnosis contribute to market growth. Additionally, advancements in EEG technology enhance its appeal for non-invasive diagnostics, making it a preferred choice for monitoring brain activity. This trend is expected to continue, bolstering the market's expansion.

Restraint:

Limited access in developing regions

Limited access to advanced EEG technology in developing regions hinders market growth. High costs and inadequate healthcare infrastructure discourage investments in these areas. Moreover, restricted reimbursement policies for EEG services further limit adoption. Smaller hospitals and clinics often lack the resources to purchase and maintain sophisticated EEG systems, creating barriers to widespread adoption.

Opportunity:

Integration of Ai and machine learning

The integration of AI and machine learning in EEG analysis presents significant opportunities for market growth. These technologies enhance diagnostic accuracy and enable predictive insights, fostering innovation in personalized medicine. Furthermore, AI-driven EEG systems can automate data interpretation, reducing the need for specialized expertise. Additionally, strategic collaborations and research funding are crucial for capitalizing on these opportunities, driving the development of more sophisticated EEG devices.

Threat:

Competition from alternative neuroimaging techniques

EEG devices face competition from advanced neuroimaging tools like MRI, CT, and PET scans, which offer higher spatial resolution for structural brain assessments. While EEG excels in temporal resolution and cost-effectiveness, preference for multi-modal diagnostics in complex cases challenges its standalone use. Additionally, rising R&D investments in alternative technologies may divert focus, necessitating continuous innovation in EEG systems to maintain relevance.

Covid-19 Impact:

The COVID-19 pandemic highlighted the importance of remote monitoring technologies, including EEG devices. However, supply chain disruptions and budget constraints initially slowed market growth. As economies recover, the focus on telehealth and home-based monitoring solutions has increased, benefiting the EEG market. Furthermore, the pandemic accelerated the adoption of digital health technologies, positioning EEG devices for long-term growth.

The hospitals and clinics segment is expected to be the largest during the forecast period

The hospitals and clinics segment is expected to account for the largest market share during the forecast period, due to high patient footfall, advanced infrastructure, and skilled personnel. These settings utilize EEG for critical diagnoses, surgical monitoring, and research, supported by favorable reimbursement policies. Additionally, partnerships with academic institutions for clinical trials reinforce segment leadership. The U.S. led in hospital-based EEG adoption, driven by robust healthcare frameworks and rising neurological disorder prevalence.

The wearable devices segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the wearable devices segment is predicted to witness the highest growth rate, fueled by demand for home-based monitoring and chronic disease management. Lightweight, wireless designs enhance patient comfort, enabling long-term data collection. Moreover, integration with smartphones and IoT platforms supports real-time analytics, appealing to both consumers and clinicians. Startups focusing on epilepsy and sleep disorder wearables drive innovation, positioning this segment for rapid expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced healthcare systems, high R&D investments, and strong presence of key players like Natus Medical and Cadwell Industries. High neurological disorder prevalence and insurance coverage further propel demand. Additionally, FDA approvals for AI-enhanced EEG devices and government funding for brain research sustain market dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare access, rising neurological disease awareness, and expanding medical tourism. Countries like India and China invest in modernizing diagnostics, while Japan's aging population boosts demand. Furthermore, local manufacturers offering cost-effective EEG systems and partnerships with global firms accelerate market penetration, positioning the region as a high-growth hub.

Key players in the market

Some of the key players in Electroencephalography Devices Market include Natus Medical Incorporated, Medtronic plc, Nihon Kohden Corporation, Cadwell Industries, Inc., NeuroWave Systems Inc., Electrical Geodesics, Inc. (EGI), Compumedics Limited, Koninklijke Philips N.V., GE Healthcare, Advanced Brain Monitoring, Inc., Brain Products GmbH, BioSemi, Emotiv, NeuroSky, g.tec medical engineering GmbH, ANT Neuro, Cephalon A/S and Noraxon U.S.A., Inc.

Key Developments:

In January 2025, Brain Products released BrainVision Recorder 1.27.0001 and BrainVision Recorder for CGX 2.01.0102.

In January 2025, Emotiv, a global leader in EEG technology, announces its next-generation EEG Active Noise-Cancelling Earphones. These smart earphones enhance personal wellness by integrating advanced EEG technology to provide insights into cognitive performance and overall well-being-alongside exceptional sound quality.

In January 2024, Compumedics Limited is pleased to announce new MEG orders from Tsinghua and Tianjin Universities in China. These sales are via Compumedics' long-term Chinese distributor and partner, Beijing Fistar. The MEG systems, along with a host of peripherals including simultaneous EEG, stimulators, computers, and CURRY neuroimaging software, will ship to both sites in 2025. One order is for two single-helmet MEG systems, and the other is for a dual-helmet MEG system. Both will be configured for hyperscanning.

Product Types Covered:

  • 8-channel EEG
  • 21-channel EEG
  • 25-channel EEG
  • 32-channel EEG
  • 40-channel EEG
  • Multichannel EEG

Device Types Covered:

  • Standalone Devices
  • Portable Devices
  • Wearable Devices

Applications Covered:

  • Epilepsy Diagnosis
  • Sleep Disorder Diagnosis
  • Brain Injury Diagnosis
  • Dementia Diagnosis
  • Monitoring Anesthesia
  • Brain-Computer Interface (BCI)
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Laboratories
  • Academic Institutions
  • Home Healthcare

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Electroencephalography Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 8-channel EEG
  • 5.3 21-channel EEG
  • 5.4 25-channel EEG
  • 5.5 32-channel EEG
  • 5.6 40-channel EEG
  • 5.7 Multichannel EEG

6 Global Electroencephalography Devices Market, By Device Type

  • 6.1 Introduction
  • 6.2 Standalone Devices
  • 6.3 Portable Devices
  • 6.4 Wearable Devices

7 Global Electroencephalography Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Epilepsy Diagnosis
  • 7.3 Sleep Disorder Diagnosis
  • 7.4 Brain Injury Diagnosis
  • 7.5 Dementia Diagnosis
  • 7.6 Monitoring Anesthesia
  • 7.7 Brain-Computer Interface (BCI)
  • 7.8 Other Applications

8 Global Electroencephalography Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Diagnostic Centers
  • 8.4 Research Laboratories
  • 8.5 Academic Institutions
  • 8.6 Home Healthcare

9 Global Electroencephalography Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Natus Medical Incorporated
  • 11.2 Medtronic plc
  • 11.3 Nihon Kohden Corporation
  • 11.4 Cadwell Industries, Inc.
  • 11.5 NeuroWave Systems Inc.
  • 11.6 Electrical Geodesics, Inc. (EGI)
  • 11.7 Compumedics Limited
  • 11.8 Koninklijke Philips N.V.
  • 11.9 GE Healthcare
  • 11.10 Advanced Brain Monitoring, Inc.
  • 11.11 Brain Products GmbH
  • 11.12 BioSemi
  • 11.13 Emotiv
  • 11.14 NeuroSky
  • 11.15 g.tec medical engineering GmbH
  • 11.16 ANT Neuro
  • 11.17 Cephalon A/S
  • 11.18 Noraxon U.S.A., Inc.

List of Tables

  • Table 1 Global Electroencephalography Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Electroencephalography Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Electroencephalography Devices Market Outlook, By 8-channel EEG (2024-2032) ($MN)
  • Table 4 Global Electroencephalography Devices Market Outlook, By 21-channel EEG (2024-2032) ($MN)
  • Table 5 Global Electroencephalography Devices Market Outlook, By 25-channel EEG (2024-2032) ($MN)
  • Table 6 Global Electroencephalography Devices Market Outlook, By 32-channel EEG (2024-2032) ($MN)
  • Table 7 Global Electroencephalography Devices Market Outlook, By 40-channel EEG (2024-2032) ($MN)
  • Table 8 Global Electroencephalography Devices Market Outlook, By Multichannel EEG (2024-2032) ($MN)
  • Table 9 Global Electroencephalography Devices Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 10 Global Electroencephalography Devices Market Outlook, By Standalone Devices (2024-2032) ($MN)
  • Table 11 Global Electroencephalography Devices Market Outlook, By Portable Devices (2024-2032) ($MN)
  • Table 12 Global Electroencephalography Devices Market Outlook, By Wearable Devices (2024-2032) ($MN)
  • Table 13 Global Electroencephalography Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 14 Global Electroencephalography Devices Market Outlook, By Epilepsy Diagnosis (2024-2032) ($MN)
  • Table 15 Global Electroencephalography Devices Market Outlook, By Sleep Disorder Diagnosis (2024-2032) ($MN)
  • Table 16 Global Electroencephalography Devices Market Outlook, By Brain Injury Diagnosis (2024-2032) ($MN)
  • Table 17 Global Electroencephalography Devices Market Outlook, By Dementia Diagnosis (2024-2032) ($MN)
  • Table 18 Global Electroencephalography Devices Market Outlook, By Monitoring Anesthesia (2024-2032) ($MN)
  • Table 19 Global Electroencephalography Devices Market Outlook, By Brain-Computer Interface (BCI) (2024-2032) ($MN)
  • Table 20 Global Electroencephalography Devices Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Electroencephalography Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Electroencephalography Devices Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 23 Global Electroencephalography Devices Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 24 Global Electroencephalography Devices Market Outlook, By Research Laboratories (2024-2032) ($MN)
  • Table 25 Global Electroencephalography Devices Market Outlook, By Academic Institutions (2024-2032) ($MN)
  • Table 26 Global Electroencephalography Devices Market Outlook, By Home Healthcare (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.